VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical solutions derived from cellular medicine. It previously operated as Shemn Corp. before rebranding as VitaSpring Biomedical Co. Ltd. in February 2020. The company was established in 2016 and its main operations are based in Irvine, California.
Subscribe to see VITASPRING BIOMEDICAL CO. LTD.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
VITASPRING BIOMEDICAL CO. LTD. is a biotech company headquartered in Riverside, United States. It is publicly listed (VSBC) with a market capitalisation of $2.3M. Xcout tracks 2 named people at VITASPRING BIOMEDICAL CO. LTD., including Jing-Zhou Chen (CEO, President, CFO & Secretary).
A few of VITASPRING BIOMEDICAL CO. LTD.'s closest competitors — see the full list of competitors and alternatives →
Immunis, Inc. is a private, clinical-stage biotechnology company founded in 2019 and headquartered in Irvine, California, pursuing novel secretome-based therapeutics for age-related diseases.
Pharmicell develops and provides stem cell therapeutics, cell culture media, and biomedical products, alongside chemical raw materials and advanced industrial materials such as nucleosides and medical PEGs. The company serves patients, researchers, and medical institutions by offering stem cell-based treatments, contract development and manufacturing (CDMO) services, and stem cell-derived cosmetics.
Biosplice Therapeutics, Inc., formerly known as Samumed, LLC, is a private biopharmaceutical company based in San Diego, California. The company focuses on clinical developments such as pivotal trials for knee osteoarthritis.
Basilard BioTech, Inc. is a biotechnology company founded in 2019 to research and develop novel therapeutic technologies. Headquartered in Southern California, United States, the company operates within the life sciences sector.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.